Silence Therapeutics (SLNCF) Short Interest Ratio & Short Volume

Short interest is the volume of Silence Therapeutics shares that have been sold short but have not yet been closed out or covered. As of August 15th, traders have sold 1,400 shares of SLNCF short. Learn More on Silence Therapeutics' current short interest.

Silence Therapeutics saw a increase in short interest in the month of August. As of August 15th, there was short interest totaling 1,400 shares, an increase of 133.3% from the previous total of 600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Silence Therapeutics: Alvotech (0.07%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.23 billion), Aptiv PLC ($2.50 billion), Royal Caribbean Cruises Ltd. ($2.48 billion), Paychex, Inc. ($2.25 billion), Moderna, Inc. ($2.17 billion), Cencora, Inc. ($2.12 billion), Tractor Supply ($1.93 billion), Onsemi ($1.82 billion), International Paper ($1.81 billion), and Rivian Automotive, Inc. ($1.72 billion). View all of the most shorted stocks.

Short selling SLNCF is an investing strategy that aims to generate trading profit from Silence Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Silence Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SLNCF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLNCF, twice per month. The most recent reporting period available is August, 15 2024.